Tesamorelin is a synthetic peptide analogue of human growth hormone-releasing hormone (GHRH), consisting of a modified 44-amino-acid sequence designed for enhanced stability in research settings. It is manufactured using advanced Solid-Phase Peptide Synthesis (SPPS) technology and produced under strict quality management procedures to ensure excellent purity, reproducibility, and chemical stability.
Our Tesamorelin is supplied as a white to off-white lyophilized powder and is subjected to comprehensive analytical testing, including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS), providing reliable quality for scientific research applications.
| Item | Specification |
|---|---|
| Product Name | Tesamorelin |
| CAS No. | 218949-48-5 |
| Molecular Formula | C221H366N72O67S |
| Molecular Weight | 5135.86 g/mol |
| Appearance | White to Off-White Lyophilized Powder |
| Purity | ≥98% (HPLC) |
| Manufacturing Method | Solid-Phase Peptide Synthesis (SPPS) |
Values are based on the free-base molecular form commonly referenced in chemical databases.
Tesamorelin is supplied exclusively for laboratory research, including:
Available packaging options include:
For optimal stability:
Store in a tightly sealed container and protect from moisture, heat, and direct sunlight.
Each production batch undergoes comprehensive quality testing before release, including:
Supporting documents available upon request:
This product is intended for laboratory research purposes only. It is not intended for human or veterinary use, diagnostic procedures, therapeutic applications, or clinical use. It should be handled only by qualified laboratory professionals in accordance with applicable regulations.